---
$id: https://graph.org.ai/products/commodity/51161515
$type: Product
source: UNSPSC
code: "51161515"
title: "Montelukast"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Montelukast

**UNSPSC Code**: 51161515
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a bronchodilator, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MHM278SD3E. European Medicines Agency schedules Montelukast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09054MIG. Montelukast generally arises in the molecular formula C35H36CLNO3S. The term MONTELUKAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 10, no. 3, 1996, list 36.) MONTELUKAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule montelukast under HS 29334990 and SITC 51575. As of Q4 2014, MONTELUKAST remains the US FDA Preferred Term for this commodity. Montelukast bears US NLM identifiers UMLS ID C0298130 and NCI Concept Code C66189. SMILES: CLC1CC2NC(/C=C/C3CC(C(SCC4(CC4)CC(=O)O)CCC4C(C(O)(C)C)CCCC4)CCC3)CCC2CC1.

